Asthma

Launching the ‘Kamba Ya Shanga’ Project

Launching the ‘Kamba Ya Shanga’ Project

While COVID is seen as a major threat to healthcare systems and human life across the world, it has also created an opportunity to re-evaluate our healthcare environment, to fast track regulatory challenges that may have otherwise been slow to implement and it has highlighted resources within our communities that were previously overlooked in favour of the more traditional methods.

Modern Medicine – Issue 4 2021

August 11, 2021 by Asthma

Paediatric Asthma Update on the stepwise management approach

Paediatric Asthma-Update on the stepwise management approach

The 2019 and 2020 updates to the Australian Asthma Handbook (versions 2.0 and 2.1) include a major update to evidence and advice on managing asthma in infants and children. The stepwise approach to management of childhood asthma differs by age group. Before any stepwise increase in asthma preventer treatment, clinicians should reconsider the diagnosis of asthma, check the parents’ and child’s understanding of asthma management and treatment adherence, and minimise exposure to triggers and environmental tobacco smoke. Asthma should be considered as a chronic remitting and relapsing condition, with any hospital presentation representing evidence of inadequate disease control.

Modern Medicine – Issue 2 2021

April 9, 2021 by Asthma

Managing Asthma and COVID-19 Risk

Managing Asthma and COVID-19 Risk

In the face of unchartered territory and unprecedented times, there remains uncharted much to be learned about the impact of asthma on the course of SARS-CoV-2 virus infection. Although adult data suggest that asthma is a risk factor for COVID-19 morbidity and mortality, such a risk in children is unclear. Differentiating COVID- 19 from worsening asthma, or an asthma exacerbation, is challenging. There is broad consensus that asthma exacerbations should be treated aggressively and in keeping with current guideline recommendations.

Modern Medicine – Issue 4 2020

August 14, 2020 by Asthma COVID Pulmonology

Asthma, COPD and When They Coexist

Asthma, COPD and When They Coexist

Asthma and chronic pulmonary obstructive disease (COPD) are umbrella terms that describe disorders of the airways with diverse inflammatory pathways and pathophysiology. Recent advances in the understanding of the immunopathology of asthma have led to the emergence of biological agents that more precisely target disease pathways but will require a more precise understanding of those dysfunctional pathways. There are areas where the pathology and expression of airways disease in asthma and COPD overlap. The overlap between asthma and COPD presents important challenges in diagnosis as well as management.

Modern Medicine – Oct/Nov 2018

November 8, 2018 by Asthma COPD

Asthma – COPD Overlap Syndrome | A merger of 2 distinct spectrums of inflammatory airway diseases

Asthma – COPD Overlap Syndrome | A merger of 2 distinct spectrums of inflammatory airway diseases – MM1609

Most practising doctors are familiar with the diseases of Asthma and Chronic Obstructive Pulmonary Disease (COPD). Within the cohort of these two disease entities, there are patients that do not completely satisfy the criteria to be diagnosed convincingly as either asthma or COPD. While the semantics of these diseases are far more important for research purposes than the diagnostic dilemma they pose, there have been several advances in both asthma and COPD that make the distinction or recognition of an asthma COPD Overlap Syndrome (ACOS) as a clinical entity more pertinent.

Modern Medicine – September 2016

October 6, 2016 by Asthma COPD Pulmonology

Worsening Asthma In Adults Part 2: Assessment And Management Of Asthma Exacerbations

Worsening Asthma In Adults Part 2: Assessment And Management Of Asthma Exacerbations – MM1502

This second part of a two-part article discusses the assessment and management of patients who present to their GP with an asthma exacerbation. Moderate exacerbations can be managed in the community but urgent hospital transfer is required if the exacerbation is severe or the patient has high-risk features or deteriorates despite treatment.

Modern Medicine – February 2015

February 24, 2015 by Asthma Pulmonology
Verified by ExactMetrics